enow.com Web Search

  1. Ad

    related to: current updates in pharma industry in texas coronavirus

Search results

  1. Results from the WOW.Com Content Network
  2. Large-Cap Pharma Industry Outlook Dull Amid Coronavirus Woes

    www.aol.com/news/large-cap-pharma-industry...

    For premium support please call: 800-290-4726 more ways to reach us

  3. Pharma Stock Roundup: JNJ & SNY's Coronavirus Product ... - AOL

    www.aol.com/news/pharma-stock-roundup-jnj-snys...

    J&J (JNJ) to begin human clinical studies on coronavirus vaccine candidate in September. Sanofi (SNY) begins outside U.S. study on Kevzara for severe COVID-19 infection.

  4. Pharma Stock Roundup: J&J's Q3 Earnings, Pause on Coronavirus ...

    www.aol.com/news/pharma-stock-roundup-j-js...

    J&J and Lilly (LLY) pause studies on their coronavirus vaccine and antibody candidates, respectively. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...

  5. COVID-19 pandemic in Texas - Wikipedia

    en.wikipedia.org/wiki/COVID-19_pandemic_in_Texas

    The death rate in Texas was 175 for every 100,000 people, while national COVID-19 death rate was 179 per 100,000. [ 6 ] As of April 3, 2021, vaccination in Texas lagged behind the US average, with rates lower than in three of four neighboring states, having administered 12,565,129 COVID-19 vaccine doses, equivalent to 43,334 doses per-100,000 ...

  6. Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates,SNY ...

    www.aol.com/news/pharma-stock-roundup-mrk-rhhby...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Curative (company) - Wikipedia

    en.wikipedia.org/wiki/Curative_(company)

    The PPO-network health insurance plan launched in late September 2022 out of Austin, Texas, with plans to expand across other areas of the state in 2023. As of 31 December 2022, Curative has shut down its COVID-19 services business. In 2023, the company fully shifted its operations to its health insurance business.

  8. List of COVID-19 vaccine authorizations - Wikipedia

    en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

    National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...

  9. Pharma Stock Roundup: ABBV, LLY Coronavirus Product ... - AOL

    www.aol.com/news/pharma-stock-roundup-abbv-lly...

    For premium support please call: 800-290-4726 more ways to reach us

  1. Ad

    related to: current updates in pharma industry in texas coronavirus